2024 SPEAKER FACULTY

Angela Tsai - Sanofi, Oligonucleotide CMC analytical development

Angela Tsai

Senior Manager - Collaboration & External Innovation

Sanofi

Anna Dudkina - Tessera, Oligonucleotide CMC analytical development

Anna Dudkina

Head of Analytical Development

Tessera Therapeutics

Armin Delavari - Biogen, Oligonucleotide CMC analytical development

Armin Delavari

Senior Scientist

Biogen

Bao Cai, Oligonucleotide CMC analytical development

Bao Cai

Executive Director, Research Manufacturing

Sarepta Therapeutics

Carter Cooperman - Ionis, Oligonucleotide CMC analytical development

Carter Cooperman

Research Associate

Ionis Pharmaceuticals

George Bou Assaf- Biogen, Oligonucleotide CMC analytical development

George Bou-Assaf

Associate Director

Biogen

Hagen Cramer - QurAlis, Oligonucleotide CMC analytical development

Hagen Cramer

Chief Technology Officer

QurAlis

Huijun Tian - QurAlis, Oligonucleotide CMC analytical development

Huijun Tian

Director, Analytical Development & Quality Control

QurAlis

Isaiah Cedillo- Ionis, Oligonucleotide CMC analytical development

Isaiah Cedillo

Executive Director, Manufacturing & Operations

Ionis Pharmaceuticals

Janine Tom - Amgen, Oligonucleotide CMC analytical development

Janine Tom

Senior Principal Scientist

Amgen

John Marino - NIST, Oligonucleotide CMC, analytical development

John Marino

IBBR Co-Director

National Institute of Standards & Technology (NIST)

Judy Carmody - Carmody Quality Solutions, Oligonucleotide CMC analytical development

Judy Carmody

Consultant

Carmody Quality Solutions

Matt McQueen - Avidity, Oligonucleotide CMC analytical development

Matt McQueen

Associate Director

Avidity Biosciences

Mona Bill - Silence Therapeutics, Oligonucleotide CMC analytical development

Mona Bill

Senior Scientist, Analytical Chemistry CMC

Silence Therapeutics

Robert Brinson - NIST, Oligonucleotide CMC, analytical development

Robert Brinson

Research Chemist

National Institute of Standards & Technology (NIST)

Satya Kuchimanchi - Camp4, Oligonucleotide CMC analytical development

Satya Kuchimanchi

Senior Vice President - Technical Operations, Chemistry, Manufacturing & Controls

CAMP4 Therapeutics

Tao Wei - Sarepta Therapeutics, Oligonucleotide CMC analytical development

Tao Wei

Associate Director, Ribonucleic Acid Process Development

Sarepta Therapeutics

Xiao - Biogen, Oligonucleotide CMC analytical development

Xiao Zhou

Senior Scientist

Biogen

yangsheng wu - Hongene, Oligonucleotide CMC, analytical development

Yansheng Wu

Vice President & Global Head of Chemistry Manufacturing Control & Regulatory

Hongene Biotechnology

2024 EVENT GUIDE